Conrad, MD, LeClair, N, Arinaitwe, E, Wanzira, H, Kakuru, A, Bigira, V, Muhindo, M, Kamya, MR, Tappero, JW and Greenhouse, B (2014) Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children. Journal of Infectious Diseases 210, 344–353.
Danquah, I, Coulibaly, B, Meissner, P, Petruschke, I, Muller, O and Mocken-haupt, FP (2010) Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in in north-western Burkina Faso. Acta Tropica 114, 63–66.
Dokomajilar, C, Lankoande, ZM, Dorsey, G, Zongo, I, Ouedraogo, JB and Rosenthal, PJ (2006) Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso. American Journal of Tropical Medicine and Hygiene 75, 162–165.
Feng, J, Yan, H, Feng, XY, Zhang, L, Li, M, Xia, ZG and Xiao, N (2014) Imported malaria in China, 2012. Emerging Infectious Diseases 20, 1778–1780.
Feng, J, Li, J, Yan, H, Feng, MY and Xia, ZG (2015) Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China. Antimicrobial Agents and Chemotherapy 59, 326–330.
Froberg, G, Jornhagen, L, Morris, U, Shakely, D, Msellem, MI, Gil, JP, Bjorkman, A and Martensson, A (2012) Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar. Malaria Journal 11, 321.
Gama, BE, Pereira-Carvalho, GA, Lutucuta Kosi, FJ, Almeida de Oliveira, NK, Fortes, F, Rosenthal, PJ, Daniel-Ribeiro, CT and Ferreira-da-Cruz, MF (2010) Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene. Malaria Journal 9, 174.
Guan, YY, Tang, LH, Hu, L, Feng, XP and Liu, DQ (2005) The point mutations in Pfcrt and Pfmdr1 genes in Plasmodium falciparum isolated from Hainan Province (in Chinese). Chinese Journal of Parasitology and Parasitic Diseases 23, 135–139.
Henriques, G, Hallett, RL, Beshir, KB, Gadalla, NB, Johnson, RE, Burrow, R, Schalkwyk, DA, Sawa, P, Omar, SA, Clark, TG, Bousema, T and Sutherland, CJ (2014) Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. Journal of Infectious Diseases 210, 2001–2008.
Huang, F, Tang, L, Yang, H, Zhou, S, Liu, H, Li, J and Guo, S (2012) Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China. Malaria Journal 11, 243.
Lin, JT, Juliano, JJ and Wongsrichanalai, C (2010) Drug-resistant malaria: the era of ACT. Current Infectious Disease Reports 12, 165–173.
Liu, Y, Zhang, HW, Zhou, RM, Yang, CY, Qian, D, Zhao, YL and Xu, BL (2014 a) First imported relapse case of Plasmodium vivax malaria and analysis of its origin CSP sequencing in Henan Province, China. Malaria Journal 13, 448.
Liu, YB, Hsiang, MS, Zhou, HY, Wang, WM, Cao, YY, Gosling, RD, Cao, J and Gao, Q (2014 b) Malaria in overseas labourers returning to China: an analysis of imported malaria in Jiangsu Province, 2001–2011. Malaria Journal 13, 29.
Liu, Y, Zhou, RM, Qian, D, Yang, CY and Zhang, HW (2014 c) Analysis of malaria epidemiological characteristics in Henan Province from 2005 to 2013(In Chinese). Chinese Journal of Parasitology Parasitic Diseases 32, 419–422.
Lucchi, NW, Komino, F, Okoth, SA, Goldman, I, Onyona, P, Wiegand, PE, Juma, E, Shi, YP, Barnwell, JW, Udhayakumar, V and Kariuki, S (2015) In vitro and molecular surveillance for antimalarial drug resistance in Plasmodium falciparum parasites in Western Kenya reveals sustained artemisinin sensitivity and increased chloroquine sensitivity. Antimicrobial Agents and Chemotherapy 59, 7540–7547.
Maberti, S (1960) Development of resistance to pyrimethamine, presentation of 15 cases studied in Trujillo, Venezuela. Archivos Venezolanos De Medicina Tropical Y Parasitología Médica 3, 239–259.
Mehlotra, RK, Fujioka, H and Roepe, PD (2001) Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proceedings of the National Academy of Sciences of the USA 98, 12689–12694.
Mok, S, Imwong, M, Mackinnon, MJ, Sim, J, Ramadoss, R, Yi, P, Mayxay, M, Chotivanich, K, Liong, KY, Russell, B, Socheat, D, Newton, PN, Day, NPJ, White, NJ, Preiser, PR, Nosten, F, Dondorp, AM and Bozdech, Z (2011) Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics 12, 391.
Moore, DV and Lanier, JE (1961) Observations on the two Plasmodium falciparum infections with an abnormal response to chloroquine. American Journal of Tropical Medicine and Hygiene 10, 5–9.
Muller, O, Sie, A, Meissner, P, Schirmer, RH and Kouyate, B (2009) Artemisinin resistance on the Thai-Cambodian border. The Lancet 374, 1419.
Mvumbi, DM, Kayembe, J, Situakibanza, H, Bobanga, TL, Nsibu, CN, Mvumbi, GL, Melin, P, Mol, PD and Hayette, M (2015) Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic review. Malaria Journal 14, 354.
Mwai, L, Kiara, SM, Abdirahman, A, Pole, L, Rippert, A, Diriye, A, Bull, P, Marsh, K, Borrmann, S and Nzila, A (2009) In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrobial Agents and Chemotherapy 53, 5069–5073.
Nsobya, SL, Dokomajilar, C, Joloba, M, Dorsey, G and Rosenthal, PJ (2007) Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda. Antimicrobial Agents and Chemotherapy 51, 3023–3025.
Ojurongbe, O, Ogungbamigbe, TO, Fagbenro-Beyioku, AF, Fendel, R, Kremsner, PG and Kun, JFJ (2007) Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria. Malaria Journal 6, 41.
Peters, W (1987) Chemotherapy and Drug Resistance in Malaria, 2nd Edn. London: Academic Press, p. 542.
Plucinski, MM, Talundzic, E, Morton, L, Dimbu, PR, Macaia, AP, Fortes, F, Goldman, I, Lucchi, N, Stennies, G, MacArthur, JR and Udhayakumar, V (2015) Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uige Provinces, Angola. Antimicrobial Agents and Chemotherapy 59, 437–443.
Reyes, S (1981) Malarial infections with Plasmodium falciparum resistant to chloroquine treatment. The situation in Braxil (1960–1981). Revista brasileira de malariologia e doenças tropicais. Publicações Avulsas 33, 109–130.
Ridley, RG (2002) Medical need, scientific opportunity and the drive for anti-malarial drugs. Nature 415, 686–693.
Roper, C, Pearce, R, Bredenkamp, B, Gumede, J, Drakeley, C, Mosha, F, Chandramohan, D and Sharp, B (2003) Antifolate antimalarial resistance in southeast Africa: a population-based analysis. The Lancet 361, 1174–1181.
Sisowath, C, Ferreira, PE, Bustamante, LY, Dahlstrom, S, Martensson, A, Bjorkman, A, Krishna, S and Gil, JP (2007) The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Tropical Medicine & International Health 12, 736–742.
Thomas, SM, Ndir, O, Dieng, T, Mboup, S, Wypij, D, Maguire, JH and Wirth, DF (2002) In vitro chloroquine susceptibility and PCR analysis of Pfcrt and Pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. American Journal of Tropical Medicine and Hygiene 66, 474–480.
Trape, JF, Pison, G, Spiegel, A, Enel, C and Rogier, C (2002) Combating malaria in Africa. Trends in Parasitology 18, 224–230.
Van Tyne, D, Dieye, B, Valim, C, Daniels, RF, Sene, PD, Lukens, AK, Ndiaye, M, Bei, AK, Ndiaye, YD, Hamilton, EJ, Ndir, O, Mboup, S, Volkman, SK, Wirth, DF and Ndiaye, D (2013) Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal. Malaria Journal 12, 441.
Vitoria, M, Granich, R, Gilks, CF, Gunneberq, C, Hosseini, M, Were, W, Raviqlione, M and De Cock, KM (2009) The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives. American Journal of Clinical Pathology 131, 844–848.
Wang, ZL, Shrestha, S, Li, XL, Miao, J, Yuan, LL, Cabrera, M, Grube, C, Yang, ZQ and Cui, LW (2015) Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007–2012. Malaria Journal 14, 168.
Wellems, TE and Plowe, CV (2001) Chloroquine resistant malaria. Journal of Infectious Diseases 184, 770–776.
Wernsdorfer, WH and Payne, D (1991) The dynamics of drug resistance in Plasmodium falciparum. Pharmacology and Therapeutics 50, 95–121.
WHO (2006) Guidelines for the Treatment of Malaria. Geneva: World Health Organization
WHO (2016) World malaria report 2016. Geneva: World Health Organization.
Xu, C, Wei, QK, Li, J, Xiao, T, Yin, K, Kong, XL, Wang, YB, Cui, Y, Sun, H, Zhao, GH, Zhu, X, Yan, C and Huang, BC (2016) Haplotype and mutation analysis of drug resistance Pfcrt and Pfmdr1 gene of imported Plasmodium falciparum (In Chinese). Chinese Journal of Zoonoses 32, 1051–1057.
Yang, CY, Qian, D, Chen, WQ, Liu, Y, Zhou, RM and Zhang, HW (2016) Investigation and analysis of overseas imported malaria prevalence in Henan Province from 2012 to 2014(In Chinese). Chinese Journal of Schistosomiasis Control 28, 444–446.
Zhang, L, Zhou, SS, Feng, J, Fang, W and Xia, ZG (2015) Malaria situation in the People's Republic of China in 2014 (In Chinese). Chinese Journal of Parasitology and Parasitic Diseases 33, 321–326.
Zhou, RM, Zhang, HW, Yang, CY, Liu, Y, Zhao, YL, Li, SH, Qian, D and Xu, BL (2016) Molecular mutation profile of pfcrt in plasmodium falciparum isolates imported from Africa in Henan Province. Malaria Journal 15, 265.